Filing Details
- Accession Number:
- 0001140361-24-043696
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-18 16:05:30
- Reporting Period:
- 2024-10-16
- Accepted Time:
- 2024-10-18 16:05:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1313403 | Dominick Colangelo | 64 Sidney Street Cambridge MA 02139 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-16 | 17,500 | $3.02 | 238,437 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-10-16 | 17,500 | $41.38 | 220,937 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-10-17 | 17,500 | $3.02 | 238,437 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-10-17 | 17,500 | $40.34 | 220,937 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-10-16 | 17,500 | $0.00 | 17,500 | $3.02 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-10-17 | 17,500 | $0.00 | 17,500 | $3.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 52,500 | No | 4 | M | Direct | ||
| 35,000 | No | 4 | M | Direct |
Footnotes
- These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.
- These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.
- These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.
Billionaire Hedge Funds
